Personalized Medicine Approach In the era of personalized medicine, the decision to use GLP-1 or GIP medications should be tailored to the individuals health status, genetic predispositions, and specific weight loss challenges
Applied Sciences , 11(19), 8819
For women, estrogen fluctuations throughout the menstrual cycle impact peptide reactivity
GLP-1 medications are generally not recommended for patients with type 1 diabetes, those with a personal or family history of medullary thyroid carcinoma, or individuals with multiple endocrine neoplasia syndrome type 2
OAT Results (selected abnormal findings): Elevated fumaric acid and citric acid (mitochondrial dysfunction) High pyroglutamic acid (glutathione depletion) Elevated arabinose (yeast overgrowth) Elevated methylmalonate (B12 deficiency) Elevated oxalic acid (possible gut or metabolic stress) Interpretation and Plan: Mitochondrial Support: Added L-carnitine, CoQ10 to support cellular energy
At 5mg/mL, a 1mg starting dose equals 20 units on your insulin syringe , which is easy to read and measure accurately